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Abstract
Background: The goal of many proteomics experiments is to determine the abundance of proteins in biological
samples, and the variation thereof in various physiological conditions. High-throughput quantitative proteomics,
specifically label-free LC-MS/MS, allows rapid measurement of thousands of proteins, enabling large-scale studies of
various biological systems. Prior to analyzing these information-rich datasets, raw data must undergo several
computational processing steps. We present a method to address one of the essential steps in proteomics data
processing - the matching of peptide measurements across samples.
Results: We describe a novel method for label-free proteomics data alignment with the ability to incorporate
previously unused aspects of the data, particularly ion mobility drift times and product ion information. We compare
the results of our alignment method to PEPPeR and OpenMS, and compare alignment accuracy achieved by different
versions of our method utilizing various data characteristics. Our method results in increased match recall rates and
similar or improved mismatch rates compared to PEPPeR and OpenMS feature-based alignment. We also show that
the inclusion of drift time and product ion information results in higher recall rates and more confident matches,
without increases in error rates.
Conclusions: Based on the results presented here, we argue that the incorporation of ion mobility drift time and
product ion information are worthy pursuits. Alignment methods should be flexible enough to utilize all available
data, particularly with recent advancements in experimental separation methods.
Keywords: Proteomics, Ion mobility, Data alignment, Matching, Product ions
Background
Label-free proteomics
In a standard “bottom-up” proteomics experiment, pro-
teins are first digested into peptides by a proteolytic
enzyme. Peptides in this mixture are then physically sepa-
rated by Chromatography, often Liquid Chromatography
(LC). Eluting peptides are converted to gas phase ions,
which are separated in a Mass Spectrometer (MS) by
mass-to-charge ratio, and the relative abundance of each
ion is measured by a detector. LC-MS experiments uti-
lize a single mass analyzer, resulting in a retention time,
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mass-to-charge ratio, and intensity for each analyte. In LC,
tandem MS experiments, or LC-MS/MS, select precursor
ions are further fragmented into product ions, resulting
in an additional level of information for each peptide ion.
The product ions are analyzed to determine a peptide
sequence, which is used to identify the parent protein. A
recent variation of LC-MS/MS - Data Independent Acqui-
sition (DIA) - generates product ions for virtually every
precursor ion, providing tremendous utility for quantifi-
cation and identification in a single data set. Examples of
DIA include SWATH [1] and MSE [2]. In MSE, precursor
ions enter a collision cell, rapidly alternating between high
and low kinetic energy states. This “high-low switching”
fragmentation enables the measurement of both precur-
sor and product ions in a single experiment. An evenmore
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recent DIA approach to bottom-up proteomics experi-
ments - HDMSE – incorporates Ion Mobility (IM) spec-
trometry, an additional separation of peptide ions after
LC, and before MSE. IM spectrometry separates ionized
peptides based on charge and three-dimensional cross-
sectional area.
Label-free proteomics data processing
Several data processing steps are required to elucidate
individual peptide intensities from raw label-free pro-
teomics data. A typical data processing pipeline for a
label-free proteomics experiment with multiple samples
is illustrated in Figure 1. Peptide peaks must be dis-
cerned from noise, charge states determined, and isotopic
distributions identified and often combined into peptide
features. Further details regarding current peak detec-
tion, de-isotoping, and charge state detection methods
are described in Dowsey et al. [3] and Zhang et al. [4].
The LC retention times and elution order of peptides
often shift between runs. Such variations in retention
time are typically called warp. The process of correct-
ing these distortions to allow accurate matching across
runs is called de-warping. Many de-warping methods
exist, performing linear or non-linear (or both) correc-
tions of two or more samples [5]. This de-warping step
is either performed on raw profile data (prior to or inde-
pendent of peak detection and de-isotoping), or on fea-
ture data (detected peptide features). After generation of
a peptide feature set, peptide identifications are made
wherever possible, and intensity measurements of both
identified and unidentified peptides are grouped across
runs, creating a peptide-by-sample intensity array for sub-
sequent analyses. It should be noted that the order of
data processing steps may vary within different pipelines.
Figure 1 Processing label-free proteomics data. Raw data contains peptide and noise peaks, with each peptide presenting as several peaks due
to multiply charged ions and the presence of different isotopes (i.e. the presence of one or more 13C). Ideally, all true peptide peaks are found and
combined into a single peak per peptide (though different charge states are often left as multiple features). A common peak detection and
de-isotoping technique is to repeatedly determine the most intense peak in the dataset, and determine the charge state and isotopic distribution
from the frequency and intensity of the neighboring peaks. The LC retention times and elution order of peptides often shift between runs. The
process of correcting these distortions to allow accurate matching across runs is called de-warping. De-warping is either performed on raw profile
data, or feature data. After de-warping, peptide features are matched across samples.
Benjamin et al. BMC Bioinformatics 2013, 14:364 Page 3 of 14
http://www.biomedcentral.com/1471-2105/14/364
These data processing steps pose significant computa-
tional challenges, and are thought to be the source of
much irreproducibility. This was illustrated by a recent
test study by Bell et al. [6]. In the study, a sample of
20 proteins was distributed to 27 different labs, experi-
mentally analyzed, and subjected to a variety of compu-
tationsl data-processing methods. There were significant
discrepancies in reported proteins, however, all raw data
was sufficient to identify all 20 proteins when centrally
re-processed.
Label-free proteomics data alignment
We focus on the problems of simple data de-warping,
and matching peptide intensities across multiple high-
throughput proteomics runs - a combined processing
step we call alignment. Our analysis emphasizes the data
matching step. Accurate alignment is essential in large-
scale proteomics experiments, particularly in biomarker
discovery where the comparative nature of these studies
require intensities of the same peptide to be compared
across samples [7,8]. In addition, accuratematching across
samples can increase identifications as information can
be leveraged from all individual runs [9]. The complexity
of biological samples, however, poses significant compu-
tational challenges for both data alignment and peptide
identification. Most samples contain tens of thousands
of peptides and measurements often reflect “overlapping”
peptides, or co-eluting peptides having nearly the same
mass-to-charge ratio. These overlapping peptides com-
plicate and often prevent identification. However, recent
experimental advancements provide additional separation
information that has not yet been leveraged in data align-
ment - namely comprehensive product ion information
with DIA, and IM drift times with HDMSE. Product ions
have been used extensively in database matching for pep-
tide identification [10,11], but are not widely used in
proteomics data alignment. Matching across samples is
typically performed using experimentally measured and
inferred characteristics of each peptide feature. Mea-
sured characteristics include precursor ion retention time,
mass-to-charge ratio, and intensity. Depending on the
experimental methods, some or all peptide features may
have additional measured characteristics including the
intensities, mass-to-charge ratios, and retention times of
product ions. In DIA experiments, virtually every peptide
feature has measured product ion data. In HDMSE exper-
iments, all precursor and product ions have a measured
IM drift time as well. Inferred characteristics include
charge state for nearly every peptide feature, and an
amino acid sequence for some peptide features. Modern
high-throughput proteomics experiments offer a great
deal of information, not all of which is currently uti-
lized in data processing - specifically in data alignment
steps.
Previous alignment approaches
Matching methods utilize various aspects of the data to
group peptide measurements across samples. Previously
utilized characteristics include retention time, mass-to-
charge ratio, intensity, and amino acid sequence. Incor-
porating additional data provides a higher degree of
specificity when making matches [5]. The majority of
existing alignment techniques utilize mass-to-charge ratio
and retention time information. Such methods include
SpecArray [12], AMT tag approaches [13], Xalign [14],
MZmine [15], msInspect [16], XCMS [17], PETAL [18],
OpenMS [19,20], apLCMS [21], andMZmine2 [22]. Semi-
supervised approaches such as PEPPeR [23] and a method
by Fischer et al. [24], take advantage of existing MS/MS
peptide identifications. More recent alignment methods
by Tang et al. [25] and Zhang et al. [26] utilize pep-
tide intensity along with mass-to-charge ratio and reten-
tion time. SuperHirn [27] indirectly incorporates intensity
information during multiple alignments by performing
pairwise alignments in a specific order based on LC-MS
similarity and intensity correlations.
In addition to utilizing novel data characteristics, our
method is designed to avoid common pitfalls of other
approaches including static distance cutoffs, elution order
assumptions, and the selection of a single reference sam-
ple. Methods should not rely on the fact that peptides
always elute in the same order from the LC column as this
is a false assumption and can introduce matching errors
[28-30]. Multiple alignment methods often require a ref-
erence run to which all other runs are aligned. While this
approach is successful for the de-warping step, choos-
ing a single reference run for the matching step can be
problematic. If the measurement variability is high in the
reference sample, this can result in incorrect matches.
We present a novel statistical alignment method that
corrects for linear global variation, is not restricted by
static distance cutoffs, and has the ability to utilize reten-
tion time, mass-to-charge ratio, peptide identifications,
and previously ignored aspects of proteomics data - ion
mobility drift times, and product ion data. Our method
is an adapted Bayesian Dirichlet Process Gaussian Mix-
ture Model (DPGMM) [31,32], adding sample-specific
shift and scale parameters. The proposed method is also
easily extensible to incorporate additional dimensions,
such as a second LC separation. We present the results
of our alignment model on various datasets, comparing
alignment accuracies with the inclusion of various data
characteristics.
Results
E. coli lysate data
To assess both the performance of our alignment method,
and the utility of various data characteristics, we aligned
technical replicates of E. coli lysate data. Three technical
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replicates of 500ng of E. coli lysate were analyzed with
Waters MSE and HDMSE. The MSE data was used to
compare our alignment method with PEPPeR [23], and
the feature matching functionality of OpenMS [19,20].
The PEPPeR PeakMatch module was downloaded from
GenePattern [33] and run locally using default parame-
ter settings. Similarly, theMapAlignerPoseClustering, and
FeatureLinkerUnlabeled functions of OpenMS version
1.11.0 were run using default parameter settings to align
peptide features of MSE data. The HDMSE data was used
to compare the results of our alignment method when
utilizing various data characteristics. Table 1 shows the
four different combinations of data characteristics utilized
for alignment. We assess alignment performance using
held-out peptide identifications resulting from product
ion spectra.
The MSE E. coli lysate data was aligned using PEPPeR,
OpenMS, and our alignment method, utilizing precur-
sor ion mass-to-charge ratio and retention time (MZ-
RT). Each alignment method was provided with the
same 15 “given matches” to initialize model hyperpa-
rameters – the 15 identifications shared by all three
replicates having the highest average ProteinLynx Global
SERVER (PLGS) IdentityE [34] peptide score. When
assessing alignment performance, we examine matches
between each replicate pair – ID0821901 vs. ID0821902,
ID0821901 vs. ID0821903, and ID0821902 vs. ID0821903.
Correct matches occur when two identified peptides
shared between the pair of technical replicates are aligned.
Mismatches occur when two identified peptides with con-
flicting identifications are aligned. Since PEPPeR allows
multiple peptides from a single sample to be present in
a “cluster”, there may be more than one identification
from a single replicate. In these cases, we counted a cor-
rect match if shared identifications were present in the
same cluster. Similarly, we counted a mismatch if conflict-
ing identifications were present in the same cluster. As
there are varying levels of confidence in peptide identifi-
cations, we present the results of each alignment method
considering identifications having a PLGS IdentityE [34]
peptide score of five, six, and seven or greater. Panels A
and B of Figure 2 show the recall rate and the mismatch
Table 1 Alignments and data utilization
Alignment Parent ion Parent ion Parent ion Production





MZ-RT-IM   
MZ-RT-IM-HE    
The alignment type names and data utilized that were compared in the analysis.
rates, respectively, for each alignment method. As PEP-
PeR does not directly report match confidence, recall and
mismatch rates were computed from all reported matches
for each method. We see that our alignment method
obtains significantly higher recall rates than OpenMS Fea-
tureLinker and PEPPeR, for identified peptides of each
confidence level. When comparing the mismatch rates,
computed as the number of mismatches divided by the
total matches, we see that our method obtains mismatch
rates comparable with OpenMS, while PEPPeR obtains
significantly higher mismatch rates, particularly at lower
peptide scores. It should be noted that this mismatch
rate is not a false positive rate. The total match count
includes many matches which cannot be identified as
correct or incorrect, as neither peptide has a putative pep-
tide sequence. When examining the total match counts
in Panel C of Figure 2, we see that our method obtains
match counts comparable to PEPPeR, and significantly
more matches than OpenMS.
The HDMSE E. coli lysate data was aligned using dif-
ferent data characteristics to compare their utility for
alignment. As with the MSE data, each alignment was
provided with the same 15 “given matches” to initialize
model hyperparameters and the remaining identifications
were used to assess alignment performance. We present
the results of each alignment only considering identifica-
tions having a PLGS IdentityE [34] peptide score of five
or greater. Results at additional peptide score thresholds
are provided in Additional file 1. Comparing the HDMSE
alignments with various data combinations informs about
the utility of each dimension in data alignment. We exam-
ine matches between each replicate pair – ID0822001 vs.
ID0822002, ID0822001 vs. ID0822003, and ID0822002 vs.
ID0822003. A match across two samples occurs when a
measured peptide feature from each sample is assigned to
the same latent peptide feature. Panels A and B of Figure 3
show the recall rate and the rate and number of mis-
matches, respectively, for each of the four alignments. We
performed a series of two-sample t-tests assuming equal
variance for the recall rates and mismatches to assess dif-
ferences between alignments.When examining the results
of the two-dimensional parent ion alignments, MZ-RT
and MZ-IM, we see that the MZ-RT alignment obtains
significantly higher recall rates for matches of all confi-
dence levels. Utilizing all parent ion data characteristics
obtained via HDMSE with a three-dimensional align-
ment (MZ-RT-IM) results in significantly higher recall
rates than the two-dimensional alignments, with a small
increase in mismatches from the MZ-RT alignment, and
a significant increase in mismatches from the MZ-IM
alignment. When including product ion profiles, we see
significant increases in recall rates, particularly with more
confident matches. We see an insignificant increase in
mismatches from theMZ-RT andMZ-RT-IM alignments.
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Figure 2 Comparison with PEPPeR and OpenMS. Panel A shows the recall rates for the MSE E. coli lysate data, considering identifications having
peptide score 5, 6, and 7 or greater, for our method, OpenMS, and PEPPeR. Panel B shows the mismatch rate for the MSE E. coli lysate data,
considering identifications having peptide score 5, 6, and 7 or greater. The mismatch rate is computed as the number of mismatches (pairwise
match with conflicting identifications) divided by the total matches. Panel C shows a bar plot of all correct, incorrect and unidentifiable matches for
each method. Unidentifiable matches are pairwise matches where neither peptide has a putative peptide sequence, and so the accuracy cannot be
inferred.
The alignment including product ion profiles results in
much more confident matches overall. It should be noted
that the results presented for the E. coli lysate analysis
assume that all peptide identifications having an IdentityE
[34] peptide score 5 or greater are correct.We also assume
that a match of two peptides differing only by a leucine
vs. isoleucine amino acid call or by amino acid order in
the peptide sequences, still represents an mismatch. The
resulting p-values across the range of match probabil-
ity stringencies are available in Additional file 1. We also
examined the match probabilities of all shared identifica-
tions – the peptides that should be matched - between the
replicates, for each of the four alignments. Histograms of
the match probabilities are shown in Panel C of Figure 3.
We see many more confident match probabilities (near
1) of the shared identifications for the MZ-RT-IM when
comparing to both two-dimensional alignments. When
including product ion profiles with the MZ-RT-IM-HE
alignment, we also see an increase in confident match
probabilities, with a migration of all intermediate match
probabilities to near-zero.
Human with E. coli lysate decoy
In order to assess alignment performance without experi-
mental identification bias, we aligned technical replicates
of E. coli lysate data with aHuman plasma decoy, and tech-
nical replicates of Human plasma with an E. coli lysate
decoy. One technical replicate of the E. coli lysate sample
was aligned with another E. coli lysate technical replicate
combined in silico with a decoy Human plasma sample. To
combine the samples, we append the human plasma peak
list onto the peak list of one of the E. coli replicates. The
Human plasma was a pooled sample from 20 individuals,
run with 2 technical replicates. Similarly, one replicate of
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Figure 3 Alignment results using various data characteristics. Panel A shows the recall rates for the HDMSE E. coli lysate data, considering
identifications having peptide score 5 or greater, for each of the four alignments across a range of match probability cutoffs. Panel B shows the
number and rate of mismatches for the HDMSE E. coli lysate data, considering identifications having peptide score 5 or greater, obtained for each of
the four alignments, across a range of match probability thresholds. Panel C shows a histogram of the match probabilities of all shared
identifications having peptide score 5 or greater, for each of the four alignments of the E. coli lysate data. For the decoy analysis, Panel D shows the
number of matches made to the correct species, and the number of matches made to the incorrect species for each of the four alignments, across a
range of match confidence. Each group of stacked bars indicates the number of correct and incorrect matches for the indicated alignment type, for
increasing match confidence thresholds from 0.1 to 1 in 0.1 intervals.
the human plasma was aligned with another plasma tech-
nical replicate combined with an E. coli lysate sample. As
with the E. coli lysate data, we performed the four dif-
ferent alignments described in Table 1. Each alignment
was provided with the same 15 “given matches” – the 15
identifications shared by the technical replicates, and hav-
ing the highest average PLGS IdentityE [34] peptide score.
To assess alignment performance, we determine the pro-
portion of incorrect species alignments. This provides a
false discovery rate that avoids experimental identification
bias - assuming the set of shared peptides across species
is negligible [35]. Figure 3, Panel D shows the cor-
rect and incorrect species match counts for each of the
four alignments. We see that the MZ-RT-IM and MZ-
IM alignments yield similar results, while the MZ-RT
alignment obtains fewer incorrect species matches, but
fewer matches overall. The MZ-RT-IM-HE alignment
obtains the least incorrect species matches, and many
more correct species matches at reasonably confident
match levels. The results of the inverse decoy analysis
(aligning technical replicates of E. coli lysate with aHuman
plasma decoy) are available in Additional file 1: Figure S7.
Hepatitis-C and osteoarthritis data
To illustrate the utility of aligning datasets obtained from
two different tissues, we aligned MSE serum samples
of Hepatitis-C patients with MSE human urine samples
from an Osteoarthritis cohort using peptide ion mass-
to-charge ratio and retention time. Peptide identifications
from the urine samples were carried over to the serum
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via alignment. We examined the 500 peptides having the
most significant differential expression with a phenotype
of interest – Hepatitis-C treatment response. Significance
was assessed with two-sample t-tests assuming equal vari-
ance, on peptide intensities that were log-transformed,
mean-centered by sample, and standardized by peptide.
We explored the inferred identifications that were car-
ried over via alignment from urine, in order to identify
potential biomarkers. Specifically, we looked at the previ-
ously unidentified peptides exhibiting significant differen-
tial expression having an inferred identification from the
alignment results. We analyzed these inferred identifica-
tions using GATHER [36] and DAVID [37] to search for
functional and pathway enrichment. The lists of proteins
from these inferred identifications and their GATHER
and DAVID analysis results are available in the Additional
file 1. The inferred identifications of peptides exhibiting
differential expression for Hepatitis-C treatment response
totaled 42 corresponding proteins. These proteins were
significantly enriched for defense response (GO0006952 -
15 proteins), immune response (GO0006955–15 proteins),
and response to biotic stimulus (GO0009607 – 14 pro-
teins), having GATHER p-values 1.56e-9, 3.76e-9, and
9.81e-9, respectively. These functional annotations are
very much in accordance with what one would expect
with a response to viral infection, suggesting that use-
ful identifications were obtained with the alignment. In
addition, the genes encoding 6 of these proteins were
located at 14q32, indicating significant chromosome loca-
tion enrichment with GATHER p-value 1.27e-5. This is
the location of the immunoglobulin heavy locus – a region
containing genes encoding the heavy chains of antibod-
ies. Differential expression of genes in this region is also
in accordance with what one would expect for HCV
treatment response.
Discussion
We have developed a novel method for label-free pro-
teomics data alignment that incorporates aspects of the
data ignored by other open-source data alignment meth-
ods. Our alignment method incorporates ion mobility
separation data and MS/MS product ion data. Our results
suggest that the inclusion of more data characteristics
increases alignment sensitivity, and increases matching
robustness.
When comparing to OpenMS, our method obtains sig-
nificantly higher recall rates, as well as more overall
matches. This is likely due to the density of the data we use
for comparison, and the matching technique of OpenMS.
After the de-warping step, OpenMS makes pairwise
matches between samples, or “maps”, if the putative match
is the nearest neighbor and the distance to the second-
nearest neighbor is significantly greater. This results in
low false positive rates, as seen in Panel B of Figure 2.
However, in dense datasets this appears to result in lower
recall rates as many true matches are not considered. In
Panel C of Figure 2, we also observe that for OpenMS,
one pairwise combination of technical replicates shows
significantly more matches than the other pairwise com-
binations. This may be the result of selecting a single
reference sample to which all other samples are aligned.
OpenMS first selects the sample with the most features
as the reference. Each remaining sample is then aligned to
the reference, estimating a “consensus” with each pairwise
alignment. The density and number of features within
the consensus increases with each pairwise alignment,
resulting in fewer matches meeting the nearest-neighbor
criteria at each step. It should be noted that we only eval-
uated the peptide feature-based functionality of OpenMS
as a comparison to our feature-based alignment method.
The ability to work with raw data, alignment specificity
and ease-of-use of OpenMS are advantageous for many
applications.
Our alignment model before the addition of the prod-
uct ion component is very similar to PEPPeR [23] – both
methods are built on the principles of Gaussian Mixture
Models. Our results in the MSE comparison (Figure 2)
reflect the similarity of our approaches. The three main
differences between PEPPeR and our MZ-RT method are
the technique for inferring the number of mixture com-
ponents, PEPPeR’s splitting of the data by charge state,
and our constraint allowing only one measured peptide
per sample in a given mixture component. We chose to
ignore charge state information to avoid propagation of
errors from earlier data-processing steps, although align-
ments can easily be stratified by charge state with our
method.
Figure 3 illustrates the significant improvements result-
ing from the inclusion of ion mobility and product ion
data, while maintaining low levels of mismatches. In addi-
tion, the inclusion of more data – particularly the product
ion profile information – results in increased confidence
and robustness of alignment matching. We note that none
of the alignments reach a recall rate of 1. This is likely
due to to the tendency of our method to generate new
latent peptide when a confidentmatch to an existing latent
peptide does not exist. This same behaviour avoids large
numbers of false positive matches.
In our decoy experiment, we observed that the addi-
tion of product ion data results in a dramatic decrease
in false matches, this is likely due to the lack of con-
founding product ion assignments to precursor ions as
the decoy data is a separate experiment. However, if one
were utilizing product ion data to align measurements to
an AMT tag-like database, we would expect a compara-
ble situation. These results also speak to the importance
of accurate product ion to precursor ion assignment in
DIA – if peptides were well separated experimentally and
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accurate product ion assignments were made, alignment
accuracy would increase dramatically.
Aligning data from different experiments can actually
yield additional identifications, as illustrated by the align-
ment of human urine data to human serum. Due to the
diverse protein composition of different types of sam-
ples, specific peptides may be identified more easily in
certain types of samples. It is worth noting that this behav-
ior is much like spectral library searching [38], because
surrounding peptides will not confound the product ion
assignments to precursor ions. We show that the align-
ment of data from different tissues (even when only uti-
lizing precursor ion data) has utility for inferring peptide
identifications. If this were extended to a database and
data from many tissues were used to update the database,
it could have a comprehensive identification set of mea-
sured peptides, and be utilized as an additional resource
or replacement for de novo identification. This is particu-
larly useful in biomarker analyses when performing a label
free experiment for an initial analysis, and then identify-
ing proteins of interest for a subsequent targeted analysis.
Also, the addition of product ion data will provide more
confident alignments, and thus more confidence in iden-
tifications that may be carried over.
Althoughwe argue that the incorporation of product ion
data can result in more matches of increased confidence,
it should be noted that the method in which these data are
incorporated has importance. If the presence of additional
product ions, or the lack of product ions is highly penal-
ized, alignments are likely to obtain fewer matches due
to the variability in measurement of product ions. Con-
versely, if differences in product ions are not penalized
enough, alignments are likely to obtainmorematches, and
more mismatches – particularly because nearby peptides
with respect to mass-to-charge ratio, retention time and
drift time, will be those with incorrect, but similar prod-
uct ion profiles. When incorporating product ion data,
researchers should consider the penalization of extra and
missing product ions within the data being aligned. We
found that similarity functions based on sums rather than
products worked well, specifically, the sum of squared
differences. Our exploration of other product ion profile
similarity functions is described in Additional file 1.
Conclusions
Wehave developed a flexible alignmentmethod that effec-
tively incorporates two data characteristics novel to open-
source peptide feature matching. Our method provides
accurate and robust matches between samples or datasets
with measures of confidence. We also show that pep-
tide feature alignment of disparate data sets has utility in
biomarker analyses, as the ability to identify certain pro-
teins may vary by tissue. The results presented here pro-
vide motivation for further exploration of incorporating
additional separation information into proteomics data
processing, particularly as experimental advancements
are made in the field.
Methods
Alignment model
We present a statistical model for the alignment of label-
free proteomics data to match peptide features across
multiple samples after peak-detection and de-isotoping.
Unlike any existing proteomics alignment method, our
model has the ability to utilize ionmobility drift time from
HDMSE experiments, and product ion spectra from tradi-
tional LC-MS/MS Data Dependent Aquisition (DDA), or
DIA (MSE or HDMSE) experiments, along with the typ-
ical parent ion mass-to-charge ratio and retention time -
increasing the individuality of each peptide feature and
providing a better alignment. At the time of publication,
no open-source proteomics file format was capable of
storing ion mobility separation data. In order to allow
incorporation of this data into our alignment method,
we wrote a small data-processing script to read Waters
‘spectrum.xml’ and ‘finalfrag.csv’ files into a Matlab data
frame. The Matlab data frame format, a sample configua-
tion file, a sample queue submission file, and the data
processing script are available in Additional files 1, 3, 4
and 5, respectively, and can be easily adapted to incorpo-
rate any additional separation dimensions similar to ion
mobility drift times and liquid chromatography retention
times, including retention times from multidimensional
LC.
Model
We adapt a DPGMM [31,32] by adding sample-specific
shift and scale parameters. GaussianMixture Models lend
themselves well to the problem of proteomics data align-
ment. Each peptide existing in nature has a theoretical
mass-to-charge ratio, retention time, etc. within a spe-
cific experimental condition, and is represented in our
model as a mixture component. We expect the mea-
surement of a peptide to have the same mass-to-charge
ratio, retention time, etc., with two different types of
measurement error: systematic error and random error.
As with any laboratory experiment, LC-MS/MS data are
subject to variability. The LC retention times often shift
between runs. Pressure fluctuations, changes in column
temperature, columnmanufacturing differences, and pep-
tide interactions can cause changes in the elution time,
and/or the elution order of peptides [13]. The mass-to-
charge ratios are also subject to measurement error, albeit
to a lesser degree than the LC dimension. We account for
systematic error with a global shift and scale. Such a trans-
formation would most likely be the result of variations
in LC protocols (total run times), or in the time it takes
for the first peptide to elute from the column (gradient
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delays due to different tubing volumes). The remaining
random error is assumed to be a sum of small variations
from many independent sources of variation, and there-
fore have a Gaussian distribution. In addition, Gaussian
distributions are closed under linear transformations,
allowing straightforward computation of posterior distri-
butions with the addition of the shift and scale parameters.
Measurements assigned to the same mixture component,
or latent peptide, by the model are considered to be
matched.
Seed peptide matches are determined with identified
peptide sequences and charge states. To avoid introducing
error with incorrect identifications, outliers with respect
to mass-to-charge ratio and retention time are discarded.
These matches are used to initialize hyperparameters, and
remain matched at all iterations of the MCMC. Mixture
component assignments are given a Chinese Restaurant
Process prior, allowing the addition of a new latent peptide
if no suitable match exists. Our model addresses simple
linear de-warping of the data, however, any preferred de-
warping method may be applied prior to utilizing our
algorithm. We first describe the model for peptide-level
alignment, and then describe the extension to include
productions.
Peptide-level model
A sample-specific linear shift (ηd) and scale (βd) is used
for de-warping. In the formulas that follow, samples or
datasets are indexed by d, individual measured peptides
within a sample are indexed by i, and latent (theoretical)
peptides are indexed by j. As shown in Equation 1, we
assume that a measured peptide feature, xd,i, is a shifted
and scaled noisy measurement of a “true” peptide fea-
ture, zcd,i . Let cd,i be an indicator variable for the latent
peptide assignment of measurement xd,i, taking on values
j = 1 . . . J where J is unbounded.
xd,i = ηd + zcd,iβd + d,i (1)
d,i ∼ Normal(0,) (2)
zcd,i ∼ Normal(μcd,i , σ) (3)
Where d,i are the residuals between the measured
values (xd,i) and the shifted and scaled latent values
(ηd + zcd,iβd), having a multivariate normal distribution -
Equation 2. Let  be the covariance of these residuals,
and let each latent peptide zcd,i be a draw from DPGMM
mixture component cd,i = 1 . . . J having mean μcd,i and
covariance σ , as shown in Equation 3. Note that we make
the simplifying assumption of shared covariance across all
latent peptides. This would suggest that the measured val-
ues of each latent peptide show the same variation across
the entire mass-to-charge ratio, retention time, and drift
time range. We acknowledge that this is not likely the
case, although we find this assumption works well in prac-
tice. Conjugate priors are used for all model parameters as
follows:
ηd ∼ Normal(ad, bd) (4)
βd ∼ Normal(ed, fd) (5)
 ∼ Inverse − Wishart(s, t) (6)
μj ∼ Normal(λ, r) (7)
σ ∼ Inverse − Wishart(g, h) (8)
Normal priors are assigned to the shift and scale param-
eters as shown in Equations 4 and 5. The seed matches,
for each peptide feature are averaged to generate a list of
“implied-identified peptides”. Robust fit linear regression
is performed for each dataset using the “implied-identified
peptides” as predictors, and the measured identified pep-
tides as response. The resulting intercept is taken as the
mean hyperparameter in the shift prior distribution (ad).
Similarly, the coefficient is taken as the mean hyperpa-
rameter in the scale prior distribution (ed). The variance
parameters on the shift and scale priors (bd and fd) are
set tightly to the variance of the regression estimate. This
allows an optimal solution to be reached as latent peptides
are updated and added, while reducing shift and scale
identifiability issues. Both the match covariance (), and
latent peptide covariance (σ ) matrices are given conju-
gate inverse-Wishart priors as shown in Equations 6 and 8.
The residuals of the shifted and scaled identified peptide
measurements, and their respective “implied-identified
peptides” are used set hyperparameters. The degrees of
freedom parameters (h and t) are set to the number
of identified matches minus one, and the inverse-scale
matrix is set to the sum of squared residuals. The mean of
each latent peptide (μj) is given a conjugate normal prior
with as shown in Equation 7. The prior mean (λ) is set
to the empirical mean of all measured peptide features
in all datasets, and the prior covariance (r) is set to the
sum of squared differences between this empirical mean
and all measured data. We express the likelihood of xd,i as
follows:
P(xd,i |η,β ,, z1...zJ , cd,i) = Normal(xd,i | ηd + zcd,iβd,)
(9)
Where z1...zJ indicates all existing latent peptides.Wemay
also integrate out zcd,i and re-express the likelihood as:
P(xd,i |η,β ,,μ1...μJ , σ , cd,i) = Normal(xd,i | Acd,i ,Bd)
(10)
Acd,i = ηd + μcd,iβd
Bd = βTd σβd + 
The prior probability of an observation, xd,i, being
assigned to latent peptide component j given all other
assignment indicators, c−(d,i), is given in Equation 11. The
Benjamin et al. BMC Bioinformatics 2013, 14:364 Page 10 of 14
http://www.biomedcentral.com/1471-2105/14/364
notation c−(d,i) refers to all component indicators from
all features in all datasets, except d, i. Similarly the prior
probability of observation xd,i being assigned to a new
latent peptide component is shown in Equation 12.
p(cd,i = j | c−(d,i),α) =
n−(d,i),j
N − 1 + α × I(! ∃i, cd,−i = cd,i)
(11)
p(cd,i = c−(d,i) | c−(d,i),α) = αN − 1 + α (12)
Let α be the DPGMM concentration parameter, N the
total number of observed peptide features across all sam-
ples, and n−(d,i) the number of observed peptide features
other than xd,i assigned to latent peptide j. A constraint
is imposed such that only one measurement per dataset
may be assigned to a given latent peptide feature. The
concentration parameter of the Dirichlet Process (α) is
set to the number of peptide feature observations across
all samples being aligned. Latent peptide feature assign-
ments are updated from their full conditional posterior
distributions, as shown in Equation 13.
P(cd,i = j | −) ∝ αN − 1 + α ×
∫
P(xd,i | −)





N − 1 + αNormal(xd,i |Acd,i ,Bd)
× I(! ∃i, cd,−i = cd,i) (13)
The integral above is tractable due to the shared
covariance across latent peptide components. Further
details and full conditional distributions are available in
Additional file 1. Panel A of Figure 4 shows a plate diagram
of the peptide level alignment model.
Productionmodel extension
To incorporate production data, we select up to the 50
most intense productions for each peptide feature mea-
surement, xd,i. We then generate aK-dimensional produc-
tion intensity profile for each xd,i. Each position, yd,ik , in
the product ion intensity profile, yd,i, is computed as:
yd,ik =
∑
p 	p × I(Mp ≤ Bk)∑
p 	p
(14)
where k = 1 . . .K , p = 1 . . . 50,	 is a 50-dimensional vec-
tor of intensities,M is a 50-dimensional vector of product
ion mass-to-charge ratios, and B is a K-dimensional vec-
tor of product ion profile mass-to-charge ratio bin upper
limits. All values in yd,i sum to one. The mass-to-charge
ratio ranges, or bins (Bk), are determined at the initial-
ization of the alignment, such that bin boundaries fall
on mass-to-charge ratio “deserts”. See the Parellelization
section and Figure 5 for a detailed description of bin
boundary determination. In the experiments described
here, we set K = 250 to ensure most product ions would be
assigned to their own bin in the product ion profile, and
to avoid additional computational complexity. Each exist-
ing latent peptide feature is given a K-dimensional product
ion profile (wj for latent peptide feature zj). To assess the
similarity of a measured product ion profile, yd,i, and a
latent production profile, wcd,i , we introduce a similarity
score, ψ , which is computed as the sum of squared dif-
ferences of the two product ion intensity profiles, and is
assumed to have an exponential distribution to encourage
distances close to zero, as shown in Equations 15 and 16.
ψd,i = (ydi − wcd,i)T (yd,i − wcd,i) (15)
ψd,i ∼ Exponential(γ ) (16)
We assign a conjugate gamma prior to the rate parameter,
as shown in Equation 17. The hyperparameters for profile
scores are set to one.
γ ∼ Gamma(a0, b0) (17)
At each iteration of the MCMC, the product ion profile,
wj of an existing latent peptide is updated empirically –
the product ion profile is set to the average of the mea-
sured product profiles assigned to that latent peptide. The
latent product ion profile, w0, of a new latent peptide (one
that currently does not exist) is a blank profile - a uni-
form vector of size K with each element having value 1/K.
Combining the product ion model with the peptide-level
model, we have the following likelihood (Equation 18) and
conditional posterior (Equation 19):
P(xd,i, yd,i | −) = Normal(xd,i | Acd,i ,Bd)
× Exponential(ψd,i | γ )
(18)
P(cd,i = j | −) ∝ αN − 1 + α ×
∫
P(xd,i | −)
× P(μj | λ, r)dμj
× Exponential((ydi − w0)T





N − 1 + α
× Normal(xd,i | Acd,i ,Bd)
× I(! ∃i, cd,−i = cd,i)
× Exponential(ψd,i | γ )
(19)
Further details and full conditional distributions are
available in Additional file 1. We explored additional val-
ues of K, as well as implementations of different product
ion models, the results and discussions of which can also
be found in Additional file 1.
Benjamin et al. BMC Bioinformatics 2013, 14:364 Page 11 of 14
http://www.biomedcentral.com/1471-2105/14/364
Figure 4 Alignment algorithm steps and principles. Panel A shows a Plate Diagram of the DPGMM Peptide-Level Model. Panel B illustrates the
computation of a product ion profile with a small example of profile size K = 10. Panel C gives an overview of the alignment algorithm steps.
Figure 5Mass-to-charge ratio deserts. Figure 5 illustrates the mass-to-charge ratio deserts. There are subsets of the mass-to-charge ratio
dimension not occupied by any peptide features. We term these subsets mass-to-charge ratio “deserts” and utilize them to split the data for
parallelization. The deserts are empirically determined using all datasets in the alignment. Shown is a histogram of measured m/z values for E. coli
lysate data, the empirical m/z deserts are indicated with vertical red lines.




As our primary goal is obtaining a list of matches, we
are only interested in maximum a posteriori (MAP) esti-
mates of the parameters. We employ simulated annealing
on all parameters after the initial burn-in period of the
MCMC. In addition, with the exception of the latent
peptide means, the model parameters are being updated
with a large number of observations, and will have fairly
tight posterior distributions. Our model assumes that the
product ion match likelihoods are independent from the
peptide-level match likelihoods. New peptide match indi-
cators are sampled from the full conditionals for each
measured peptide in a random order. We sample match
indicators in accordance with “Algorithm 2” for sam-
pling mixture component indicators in DPGMM from
Neal, 2000. We impose a restriction on match assignment
such that only one measured peptide per dataset may
be assigned to a given latent peptide. All other parame-
ters are sampled from their full conditional distributions.
After obtaining MAP estimates for all parameters, we
then iteratively re-sample only the component assignment
indicators, keeping track of how often each measure-
ment is assigned to each latent peptide. These assignment
proportions are used to make final matches.
Estimating the best alignment
Utilizing the assignment proportions from the final
“assignment-only” MCMC iterations, we use a greedy
algorithm to determine the final alignment. The best
match (latent peptide-measurement pair) across the entire
alignment is selected, and then the assignment propor-
tions for measurements in each of the remaining datasets
are examined for the current latent peptide. For each
dataset, the measurement with the maximum assignment
proportion is selected. All remaining match probabilities
for the assignedmeasurements and the current latent pep-
tide are set to zero. This process is repeated until no
non-zero assignment proportions remain. These assign-
ment probabilities represent the probability that a given
measurement arises from a certain latent peptide. To com-
pute the match probability of two measurements from
two datasets, we compute the probability that both mea-
surements are assigned to the same latent peptide – the
product of the two individual latent peptide assignment
probabilities. Users may utilize these match probabilities
to examine matches of varying confidence. An illustration
of the algorithm steps is shown in Panel C of Figure 4.
Parallelization
In order to make alignment of large datasets tractable,
we split the datasets being aligned in the mass-to-charge
ratio dimension, and perform separate alignments of each
split in parallel. The boundaries of these splits fall only
on mass-to-charge ratio “deserts”, which are empirically
determined using all datasets being aligned. There exist
gaps - also called “forbidden zones” in the mass distribu-
tion of all possible tryptic peptides [39]. These gaps have
been utilized to improve peak de-noising techniques [40].
We calculate these gaps empirically based on the data in
question, and utilize them to split the data for alignment.
Such mass-to-charge ratio deserts are shown in Figure 5.
When determining these mass-to-charge ratio deserts, we
utilize the given matches to determine an approximate
shift, scale, and match standard deviation. We then obtain
the number of measured peptides in each mass-to-charge
ratio bin the size of match standard deviation, and split
the datasets at mass-to-charge ratio deserts defined as
stretches of five or more empty bins. This ensures that
anymeasured peptide features with the potential for being
aligned to the same latent peptide feature (any measure-
ments that should match one another) will be in the same
alignment split. The hyperparameters set in the model
initialization are shared across all alignment splits.
The boundaries of the product ion profiles are deter-
mined in a similar way. Utilizing the product ion anno-
tations of the given matches, we obtain a mass-to-charge
ratio match standard deviation of product ions. We then
obtain the number of measured product ions in each
mass-to-charge ratio bin the size of the match standard
deviation, and set the product ion profile boundaries on
mass-to-charge ratio deserts defined as stretches of three
or more empty bins. The size of the product ion profile
boundaries is as close to 1/K of the spanning product ion
mass-to-charge ratio range as possible, given the bound-
aries are set within mass-to-charge ratio deserts.
Data
All data used in this analysis was obtained under MSE
and/or HDMSE conditions (SYNAPTHDMSG2,Waters),
and subject to Waters ProteinLynx Global SERVER
(PLGS) processing. We utilize peptide features that have
already been subject to peak detection, de-isotoping,
charge state determination, and tentative identification
(although not all identifications are utilized for align-
ment). All samples were separated by 1D nanoscale
capillary ultraperformance Liquid Chromatography in
a 90-minute gradient using a 5–40% acetonitrile/water
(0.1% formic acid in each).
Three HCV cohorts were utilized in the alignment
of serum samples from HCV patients to urine sam-
ples from OA patients. The first cohort included 47
patients ages 5 to 18 years from a clinical trial for HCV
treatment [41]. The two additional HCV cohorts (n =
41,55) were selected from the Duke Hepatology Clini-
cal Research (DHCR) database [42]. The pediatric clinical
trial study was approved by the institutional review boards
of the participating sites. Written informed consent was
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provided by all parents or guardians, and written assent
was provided by all participants over 12 years of age.
All patients present in the DHCR database cohorts, as
well as all OA patients, provided written informed con-
sent, and all study procedures were approved by the Duke
University Institutional Review Board.
Analysis
All alignments were performed using Matlab on the Duke
Shared Computing Resource, a cluster of Intel x86 com-
pute notes running Linux. Each alignment was partitioned
into a maximum of 250 splits, and each alignment parti-
tion was run on a single node with at least 8GB of mem-
ory. Our method does require considerable computation
time - approximately 2 to 6 hours for the E. coli Lysate
and HCV-OA alignments not utilizing product ions, and
approximately 20–24 hours for the E. coli Lysate align-
ments utilizing product ions. Times vary by the number
and size of datasets being aligned.
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